IGF1 and metabolic dysfunction-associated steatotic liver disease: Similar to NAFLD/NASH, IGF1 treatment shows different positive hepatoprotective, antifibrogenic, antioxidant and mitochondrial-protective effects in cirrhotic livers [35].